
Meta-regression coefficients, by drug class
=========================================================================
                 Outcome               Class  Slope  CI.lb  CI.ub P-value
-------------------------------------------------------------------------
1       Cardiovascular Mortality      GLP-1RA  0.78  -3.519 5.078  0.722 
2                 MACE                GLP-1RA 0.962  -3.491 5.416  0.672 
3   Hospitalization for Heart Failure GLP-1RA 1.298  -2.506 5.103  0.504 
4        Composite Renal Outcome      GLP-1RA -0.936 -7.416 5.544  0.777 
5          All-cause Mortality        GLP-1RA 0.138  -4.364 4.641  0.952 
6         Myocardial Infarction       GLP-1RA 1.373  -3.301 6.047  0.565 
7                Stroke               GLP-1RA -0.774 -4.669 3.121  0.697 
8       Cardiovascular Mortality      SGLT2i  0.487  -0.027   1    0.063 
9                 MACE                SGLT2i   1.88  -0.111 3.872  0.064 
10  Hospitalization for Heart Failure SGLT2i  1.444  1.046  1.842    0   
11       Composite Renal Outcome      SGLT2i  0.192  -0.549 0.932  0.612 
12         All-cause Mortality        SGLT2i  0.379  -0.079 0.836  0.105 
13        Myocardial Infarction       SGLT2i  -0.151 -2.785 2.484  0.911 
14               Stroke               SGLT2i  -0.074 -2.898 2.751  0.959 
-------------------------------------------------------------------------
Absolute risk difference and baseline cardiovascular mortality rate      
